Article
Epidemic MRSA clone ST22-IV is more resistant to multiple host- and environment-related stresses compared with ST228-I.
The Journal of antimicrobial chemotherapy - 1 Mar 2015
Baldan Rossella, Rancoita Paola Maria Vittoria, Di Serio Clelia, Mazzotti Maria, Cichero Paola, Ossi Cristina, Biancardi Anna, Nizzero Paola, Saracco Alberto, Scarpellini Paolo, Cirillo Daniela Maria
Abstract excerpt
BACKGROUND: ST22-IV is a successful hospital-associated MRSA clone. Due to its known ability to replace other MRSA clones in hospitals, it became a dominant clone in Europe and beyond. So far, there are no studies investigating the relationship between the epidemiological success of MRSA clones and their capacity to withstand commonly encountered stresses. METHODS: We investigated the fitness of ST22-IV in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
